Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Mycotopia Therapies (TWGL) stocks

Learn how to buy Mycotopia Therapies stock in 5 easy steps.

Mycotopia Therapies is a shell companies business based in the US. Mycotopia Therapies stocks (TWGL.US) are listed on the PINK and all prices are listed in US Dollars. Its last market close was $2.7 – an increase of 1.8% over the previous week. Mycotopia Therapies employs 1 staff and has a market cap (total outstanding stock value) of $54.9 million.

How to buy Mycotopia Therapies stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – TWGL. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Promoted for Beginners


National Bank Direct Brokerage

  • Commission-free trading
  • Several account types available
  • Access to array of research tools

Promoted for Low Fees

CIBC Investor's Edge

  • Easy to use platform
  • Low fees
  • Student and young investor discounts

Best for Lowest Commissions

Finder Award

Interactive Brokers

  • Access to international stock exchanges
  • Low margin rates
  • Powerful research tools

Mycotopia Therapies stock price (PINK:TWGL)

Use our graph to track the performance of TWGL stocks over time.

Mycotopia Therapies shares at a glance

Information last updated 2021-05-05.
Latest market close$1.70
52-week range$0.00 - $0.00
50-day moving average $3.73
200-day moving average $3.11
Wall St. target priceN/A
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $0.01

Buy Mycotopia Therapies stocks from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 5 of 5
Name Product Finder Rating Available Asset Types Stock Trading Fee Account Fee Signup Offer Table description
National Bank Direct Brokerage
Finder Rating:
4.2 / 5
Stocks, Bonds, Options, Mutual Funds, GICs
$0 if conditions met, or $100
Get $0 commission on all transactions with promo code: finder
CIBC Investor's Edge
Finder Rating:
3.8 / 5
Stocks, Bonds, Options, Mutual Funds, ETFs
$0 if conditions met, or $100
An easy-to-use platform with access to a variety of tools to help you trade with confidence.
Interactive Brokers
Finder Rating:
4.3 / 5
Stocks, Bonds, Options, ETFs, Currencies, Futures
min $1.00, max 0.5%
Winner for Best Overall Broker in the Finder Stock Trading Platform Awards.
Finder Rating:
4.3 / 5
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
$4.95 - $9.95
Get $50 in free trades when you fund your account with a minimum of $1,000.
Opt for self-directed investing and save on fees or get a pre-built portfolio to take out some of the guesswork.
Qtrade Direct Investing
Finder Rating:
3.7 / 5
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Get up to $150 sign-up bonus. Use promo code BONUS150. Conditions apply. Ends June 30, 2023.
Low trading commissions and an easy-to-use platform with access to powerful tools and a wide selection of investment options.

Mycotopia Therapies price performance over time

Historical closes compared with the close of $1.7 from 2021-05-26

1 week (2023-05-19) N/A
1 month (2023-04-26) N/A
3 months (2023-02-26) N/A
6 months (2022-11-26) N/A
1 year (2022-05-26) N/A
2 years (2021-05-28) 10.39%
3 years (2020-05-29) 2,733.33%
5 years (2018-05-30) 372.22%

Is Mycotopia Therapies stock undervalued or overvalued?

Valuing Mycotopia Therapies stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Mycotopia Therapies's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Mycotopia Therapies financials

Gross profit TTM $0
Return on assets TTM -11.93%
Return on equity TTM -28.43%
Profit margin 0%
Book value $0.04
Market capitalisation $54.9 million

TTM: trailing 12 months

Mycotopia Therapies share dividends

We're not expecting Mycotopia Therapies to pay a dividend over the next 12 months.

Have Mycotopia Therapies's shares ever split?

Mycotopia Therapies's shares were split on a 2:1 basis on 1 May 2014. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Mycotopia Therapies shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Mycotopia Therapies shares which in turn could have impacted Mycotopia Therapies's share price.

Mycotopia Therapies share price volatility

Over the last 12 months, Mycotopia Therapies's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (PINK average) beta is 1, while Mycotopia Therapies's is 5.9937. This would suggest that Mycotopia Therapies's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Mycotopia Therapies overview

Mycotopia Therapies Inc. provides psychedelic therapies through technology-focused, data-driven, and medical-based solutions for people dealing with anxiety, depression, bipolar disorders, PTSD, ADHD, autism, and addictions. The company was incorporated in 2019 and is based in Aventura, Florida. The company operates as a subsidiary of EHAVE, Inc. .

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site